自发性细菌性腹膜炎诊断与治疗的研究进展

宋媛媛; 江宇泳

doi:10.3969/j.issn.1001-5256.2016.06.040

自发性细菌性腹膜炎诊断与治疗的研究进展

DOI: 10.3969/j.issn.1001-5256.2016.06.040

1. 首都医科大学附属北京地坛医院中西医结合中心
2. 北京中医药大学东直门医院

基金项目:

北京中医药科技基金项目(JJ2015-17)；北京市卫生系统高层次人才培养学科骨干项目(2013-3-022)；

详细信息

中图分类号: R572.2
计量
- 文章访问数: 2340
- HTML全文浏览量: 41
- PDF下载量: 507
- 被引次数: 0
出版历程
- 出版日期: 2016-06-20

Research advances in diagnosis and treatment of spontaneous bacterial peritonitis

Research funding:

摘要

摘要: 自发性细菌性腹膜炎是肝硬化腹水常见的一种并发症。其发病率高,病情进展快,病死率高。目前国内外有关自发性细菌性腹膜炎的临床诊断标准尚不统一,且有些患者的临床症状不典型,因此不少患者容易出现漏诊,延误病情。综述了国内外有关自发性细菌性腹膜炎的诊断、发病机制及治疗的相关进展,以期为临床医师提供参考,提高自发性细菌性腹膜炎的诊断率,降低临床病死率,改善患者的预后。
- 肝硬化 /
- 腹水 /
- 腹膜炎 /
- 诊断 /
- 治疗 /
- 综述
Abstract: Spontaneous bacterial peritonitis(SBP) is a common complication of cirrhotic ascites,and has a high incidence rate,rapid progression,and a high fatality rate.At present,there are no uniform diagnostic criteria for SBP at home and abroad.Some patients do not have the typical clinical symptoms of SBP,and therefore,missed diagnosis might occur in such patients and the patient's condition might be delayed.This article reviews the advances in the diagnosis,pathogenesis,and treatment of SBP,in order to provide a reference to clinical physicians,increase the diagnostic rate of SBP,reduce clinical fatality rate,and improve patients' prognosis.
- liver cirrhosis /
- ascites /
- peritonitis /
- diagnosis /
- therapy /
- review

HTML全文

参考文献(46)

[1]BIECKER E.Diagnosis and therapy of ascites in liver cirrhosis[J].World J Gastroenterol,2011,17(10):1237-1248.

[2] European Association for the Study of the Liver.EASL clinical practice guidelines on the management of ascites,spontaneous bacterial peritonitis,and hepatorenal syndrome in cirrhosis[J].J Hepatol,2010,53(3):397-417.

[3]ANGELONI S,LEBOFFE C,PARENTE A,et al.Efficacy of current guidelines for the treatment of spontaneous bacterial peritonitis in the clinical practice[J].World J Gastroenterol,2008,14(17):2757-2762.

[4]RUNYON BA.Management of adult patients with ascites due to cirrhosis:an update[J].Hepatology,2009,49(6):2087-2107.

[5]WU MC,LI MH.Practical liver diseases[M].Beijing:People's Medical Publishing House,2011:510-513.(in Chinese)吴孟超,李孟华.实用肝病学[M].北京:人民卫生出版社.2011:510-513.

[6] BIECKER E.Diagnosis and therapy of ascites in liver cirrhosis[J].World J Gastroenterol,2011,17(10):1237-1248.

[7]WU HQ,WANG H.Diagnosis and treatment of spontaneous bacterial peritonitis in cirrhotic patients with ascites[J].J Clin Hepatol,2012,28(9):651-653.(in Chinese)吴海清,王晖.肝硬化腹水伴自发性细菌性腹膜炎的诊断及治疗[J].临床肝胆病杂志,2012,28(9):651-653.

[8]DANG Y,ZHANG LL,LOU JL,et al.Ascites and plasma calcitonin angiotensinogen in patients with liver cirrhosis complicated with spontaneous bacterial peritonitis was diagnosed in value[J].J Capit Med Univ,2015,36(4):597-600.(in Chinese)党燕,张立丽,娄金丽,等.腹水及血浆降钙素原在肝硬化合并自发性细菌性腹膜炎诊断中的价值[J].首都医科大学学报,2015,36(4):597-600.

[9]WANG XT,HAN T.The relationship between intestinal micro ecology and liver disease[J].J Clin Hepatol,2015,31(4):642-645.(in Chinese)王晓彤,韩涛.肠道微生态与肝病的关系[J].临床肝胆病杂志,2015,31(4):642-645.

[10] BRON PA,MARCOM,HOFFER SM,et al.Genetic characterization of the bile salt response in Lactobacillus plantarum and analysis of responsive promoters in vitro and in situ in the gastrointestinal tract[J].JBacteriol,2004,186(23):7829-7835.

[11]FOUTS DE,TORRALBA M,NELSON KE,et al.Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease[J].J Hepatol,2012,56(6):1283-1292.

[12] QIN N,LI LJ.Alterations of the human gut microbiome in liver cirrhosis[J].Nature,2014,503(10):6840-6859.

[13]ZHOU XB,ZENG H,WANG XB.Intestinal leakage theory and spontaneous bacterial peritonitis[J/CD].Chin J Exp Clin Infect Dis:Electronic Edition,2014,8(1):114-116.(in Chinese)周小兵,曾辉,王宪波.肠渗漏学说与自发性细菌性腹膜炎[J/CD].中华实验和临床感染病杂志:电子版,2014,8(1):114-116.

[14]KIESSLICH R,GOETZ M,ANGUS EM,et al.Identification of epithelial gaps in human small and large intestine by confocal endomicroscopy[J].Gastroenterology,2007,133(6):1769-1778.

[15]CHEN P,STARKEL P,TURNER JR,et al.Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice[J].Hepatology,2015,61(3):883-894.

[16]LIU DY,CUI W.NO in vitro on intestinal epithelial cells express tight junction protein Oe.eludin effect[J].World J Gastroenterol,2007,15(21):2295.(in Chinese)刘冬妍,崔巍.NO体外对肠上皮细胞表达紧密连接蛋白Oe.eludin的影响[J].世界华人消化杂志,2007,15(21):2295.

[17] FORSYTH CB,TANG Y,SHAIKH M,et al.Role of snail activation in alcohol-induced i NOS-mediated disruption of intestinal epithelial cell permeability[J].Alcohol Clin Exp Res,2011,35(9):1635-1643.

[18]ASSIMAKOPOULOS SF,TSAMANDAS AC,TSIAOUSSIS GI,et al.Altered intestinal tight junctions expression in patients with liver cirrhosis:a pathogenetic mechanism of intestinal hyperpermeability[J].Eur J Clin Invest,2012,42(4):439-446.

[19]DU PJ,VANHEEL H,JANSSENCE,et al.Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function[J].J Hepatol,2013,58(6):1125-1132.

[20]YUE C,WANG W,TIAN WL,et al.Lipopolysaccharide-induced failure of the gut barrier is site-specific and inhibitable by growth hormone[J].Inflamm Res,2013,62(4):407-415.

[21] CATALIOTO RM,MAGGI CA,GIULIANI S.Intestinal epithelial barrier dysfuction in disease and possible therapeutical interventions[J].Curr Med Chem,2011,18(3):398-426.

[22] SUMITOMO T,NAKATA M,HIGASHINO M,et al.Group Astreptococcal cysteine protease cleaves epithelial junctions and contributes to bacterial translocation[J].J Biol Chem,2013,288(19):13317-13324.

[23]CARIELLO R,FEDERICO A,SAPONE A,et al.Intestinal permeability in patients with chronic liver diseases:its relationship with the aetiology and the entity of liver damage[J].Dig Liver Dis,2010,42(3):200-204.

[24]SIPEKI N,ANTAL-SZALMAS P,LAKATOS PL,et al.Immunedysfunction in cirrhosis[J].World J Gastroenterol,2014,20(10):2564.

[25]CERETO F,MOLINA I,GONZLEZ A,et al.Role of immunosuppression in the development of quinolone-resistant Escherichia coli spontaneous bacterialperitonitis and in the mortality of E.coli spontaneous bacterial peritonitis[J].Aliment Pharmacol Ther,2003,17(5):695-701.

[26] American Association for the Study of Liver Diseases.Guidelines for diagnosis and treatment of adult liver cirrhosis ascites[J].J Hepatol,2012,73(4):397-417.

[27]PLEGUEZUELO M,BENITEZ JM,JURADO J,et al.Diagnosis and management of bacterial infections in decompensated cirrhosis[J].World J Hepatol,2013,5(1):16-25.

[28]FERNNDEZ J,ACEVEDO J,CASTRO M,et al.Prevalence and Risk Factors of Infections by Multiresistant Bacteria in cirrhosis:a Pros-pective Study[J].Hepatology,2012,55(5):1551-1561.

[29] PLEGUEZUELO M,BENITEZ JM,JURADO J,et al.Diagnosis and management of bacterial infections in decompensated cirrhosis[J].World J Hepatol,2013,5(1):16-25.

[30]BADAWY AA,ZAHER TI,SHARAF SM,et al.Effect of alternative antibioticsin treatment of cefotaxime resistant spontaneous bacterial peritonitis[J].World J Gastroenterol,2013,19(8):1271-1277.

[31]DENG Y,LIAO Y.Analysis of risk factors for spontaneous bacterial peritonitis in patients with chronic hepatitis and cirrhosis with ascites[J].Chin J Prim Med Pharm,2011,18(16):2182-2183.(in Chinese)邓媛,廖毅.慢性肝炎肝硬化腹水并发自发性细菌性腹膜炎相关危险因素分析[J].中国基层医药,2011,18(16):2182-2183.

[32]JU LZ,CHENG RZ,GENG XP,et al.Analysis of the risk factors of spontaneous bacterial peritonitis in patients with liver cirrhosis and ascites[J].Chin J Hepatol,2011,19(8):619-620.(in Chinese)巨立中,程瑞专,耿秀萍,等.肝硬化腹水患者并发自发性细菌性腹膜炎的危险因素分析[J].中华肝脏病杂志,2011,19(8):619-620.

[33]POCM M,CONCEPCIN M,CASAS M,et al.Role of albumin treatment in patients with spontaneous bacterial peritonitis[J].Clin Gastroenterol Hepatol,2012,10(3):309-315.

[34] SALERNO F,La MURA V.Treatment of spontaneous bacterial peritonitis[J].Dig Dis,2015,33(4):582-585.

[35]XUE HP,LIN B,MO JZ,et al.Effect of albumin infusion on preventing the deterioration of renal function in patients with spontaneous bacterial peritonitis[J].Chin J Gastroenterol,2001,6(2):100-101.(in Chinese)薛惠平,林冰,莫剑忠,等.静脉滴注白蛋白预防自发性腹膜炎肾功能减退的研究[J].胃肠病学,2001,6(2):100-101.

[36]LIU Y.The value of intravenous albumin in the treatment of spontaneous bacterial peritonitis[D].Jilin University,2014.(in Chinese)刘杨.静脉输注白蛋白在自发性腹膜炎治疗中的价值探讨[D].吉林大学,2014.

[37] TIAN P,XU B,AN G,et al.WITHDRAWN:a new therapy for intestinal flora imbalance using ampicillin-resistant probiotics[J].J Microbiol Biotechnol,2014.[Epub ahead of print]

[38]MALAGUARNERA M,GARGANTE MP,MALAGUARNERA G,et al.Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy[J].Eur J Gastroenterol Hepatol,2010,22(2):199-206.

[39]CHEN C,LI L,WU Z,et al.Effects of lactitol on intestinal microflora and plasma endotoxin in patients with chronic viral hepatitis[J].J Infect,2007,54(1):98-102.

[40]ZHOU FX,LU FG,WU XP,et al.Clinical study on intestinal decontamination combined with microecologics in treatment of advanced liver cirrhosis[J].Chin J Dig,2006,26(2):125-126.(in Chinese)周伏喜,卢放根,吴小平,等.肠道去污联合微生态制剂治疗晚期肝硬化的临床研究[J].中华消化杂志,2006,26(2):125-126.

[41]DEVER JB,SHEIKH MY.Review article:spontaneousbacterialperitonitis-bacteriology,diagnosis,treatment,risk factorsand prevention[J].Aliment Pharmacol Ther,2015,41(11):1116-1131.

[42] XU HB,WANG HD,LI CH,et al.Proton pump inhibitor use and risk of spontaneous bacterial peritonitis in cirrhotic patients:a systematic review and meta-analysis[J].Genet Mol Res,2015,14(3):7490-7501.

[43]DESHPANDE A,PANT C,PASUPULETI V,et al.Association between proton pump inhibitor therapy and Clostridium difficile infection in a meta-analysis[J].Clin Gastroenterol Hepatol,2012,10(3):225-233.

[44] CHUN SK,MBBS M,AARON K,et al.Risk of clostridium difcile infection with acid suppressing drugs and antibiotics:meta-analysis[J].Am J Gastroenterol,2012,107(7):1011-1019.

[45] JANARTHANAN S,DITAH I,ADLER DG,et al.Clostridium difficile-associated diarrhea and proton pump inhibitor therapy:a meta-analysis[J].Am J Gastroenterol,2012,107(7):1001-1010.

[46]FEI Y,NI XR,ZOU MY.Analysis on the risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites[J/CD].Chin JExp Clin Infect Dis:Electronic Edition,2014,8(5):605-608.(in Chinese)费琰,倪晓蓉,邹美银.肝硬化腹水并发自发性腹膜炎的危险因素分析[J/CD].中华实验和临床感染病杂志:电子版,2014,8(5):605-608.

施引文献

资源附件(0)

访问统计